WS #4176

The data dump reveals a significant escalation in the US-Iran conflict, with multiple corroborated reports of military incidents. A US F-15E fighter jet was shot down over Iran, with one crew member rescued and the second's status uncertain. Separately, a US A-10 Warthog reportedly crashed near the Strait of Hormuz. These developments, reported by GDELT, jetstream.bsky.priority, and ANSA, indicate heightened combat losses and operational risks. Concurrently, geopolitical tensions are rising with Hezbollah missile launches towards Haifa and a US advisory for citizens to depart Lebanon immediately. This escalation could pressure oil prices and defense stocks, while increasing risk aversion in broader markets. In corporate news, AbbVie lowered its 2026 EPS outlook due to a $744M R&D charge, a specific negative signal for the pharmaceutical sector. AEON Biopharma received an additional NYSE American non-compliance notice, indicating financial distress. Several other 8-K filings (e.g., Fluence Energy, BlackRock) detail material agreements or obligations but lack immediate market-moving specifics. The US jobs report showed a surprisingly strong 178,000 additions, which could influence Fed policy expectations and bond yields. Overall, the primary signal is military escalation in the Middle East, with cross-source corroboration and direct implications for energy, defense, and risk assets. Corporate developments are company-specific, with AbbVie's guidance cut being the most material.